Autoantibody Profiling and Diagnostic Performance of Serum and Liver Tissue Markers in Patients with Autoimmune Hepatitis: A Review
DOI:
https://doi.org/10.5281/zenodo.22207592Keywords:
Autoimmune Hepatitis, Autoantibodies, Anti-SLA/LP, Diagnostic Criteria, Liver HistologyAbstract
Autoimmune hepatitis has no single diagnostic test. It is identified by assembling autoantibodies, immunoglobulin G, liver histology and the exclusion of viral disease into a score. Each component behaves differently, and the antibody most people order first is the least specific one available. Objectives: To review the published evidence on serological and histological markers in autoimmune hepatitis: how the individual autoantibodies perform, how the two diagnostic scoring systems compare, what liver biopsy contributes, and where each fails. Material and Methods: Narrative review of diagnostic accuracy studies, scoring system validations, meta-analyses and society guidance indexed in PubMed and the major hepatology and immunology journals. Studies were eligible if they reported the accuracy of an autoantibody or scoring system for diagnosing autoimmune hepatitis in a defined population, or the contribution of histology to that diagnosis. No new patient data were generated; every estimate quoted is one published by the original investigators.
Results: Pooling 29 studies, antinuclear antibodies gave a sensitivity of 65.0 per cent and specificity of 75.1 per cent, smooth muscle antibodies 59.3 and 92.6 per cent, and antibodies to soluble liver antigen 19.4 and 98.9 per cent, with diagnostic odds ratios of 7.38, 31.55 and 16.87 respectively. In 435 patients assessed by both scoring systems, the revised original system was more sensitive (100 against 95 per cent) while the simplified system was more specific (90 against 73 per cent) and more predictive (92 against 82 per cent), and excluded the diagnosis more reliably in diseases with concurrent immune features (83 against 64 per cent). The simplified criteria at a threshold of six reported sensitivity and specificity of 88 and 97 per cent in the derivation cohort, 90 and 95 per cent in a Chinese validation and 96 and 97 per cent in a German one. Conclusion: No autoantibody both identifies and confirms the disease. Antinuclear antibodies are the most frequently positive and the least discriminating; antibodies to soluble liver antigen are close to definitive when present but absent in four patients out of five. The two scoring systems fail in opposite directions and are best used for different purposes rather than as alternatives. Abbreviations: AIH – Autoimmune Hepatitis, ANA – Antinuclear Antibodies, SMA – Smooth Muscle Antibodies, anti-SLA/LP – Antibodies to Soluble Liver Antigen/Liver Pancreas, anti-LKM1 – Anti-Liver Kidney Microsomal Antibody Type 1, anti-LC1 – Anti-Liver Cytosol Antibody Type 1, IgG – Immunoglobulin G, IAIHG – International Autoimmune Hepatitis Group, PBC – Primary Biliary Cholangitis, PSC – Primary Sclerosing Cholangitis, DILI – Drug-Induced Liver Injury, DOR – Diagnostic Odds Ratio.
References
Mackay IR, Weiden S, Hasker J. "Autoimmune hepatitis". Ann N Y Acad Sci 124(1965):767-780.
European Association for the Study of the Liver. "EASL clinical practice guidelines: autoimmune hepatitis". J Hepatol 63(2015):971-1004.
Krawitt EL. "Autoimmune hepatitis". N Engl J Med 354(2006):54-66.
Johnson PJ, McFarlane IG. "Meeting report: International Autoimmune Hepatitis Group". Hepatology 18(1993):998-1005.
Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. "International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis". J Hepatol 31(1999):929-938.
Hennes EM, Zeniya M, Czaja AJ, Parés A, Dalekos GN, Krawitt EL, et al. "Simplified criteria for the diagnosis of autoimmune hepatitis". Hepatology 48(2008):169-176.
Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. "Chronic active hepatitis associated with anti liver/kidney microsome type 1: a second type of autoimmune hepatitis". Hepatology 7(1987):1333-1339.
Ballot E, Homberg JC, Johanet C. "Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis". J Hepatol 33(2000):208-215.
Villalta D, Girolami E, Alessio MG, Sargentini V, Tampoia M, Brusca I, et al. "Autoantibody profiling in a cohort of pediatric and adult patients with autoimmune hepatitis". J Clin Lab Anal 30(2016):41-46.
Czaja AJ, Donaldson PT. "Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis". Am J Gastroenterol 97(2002):2051-2057.
Zhang WC, Zhao FR, Chen J, Chen WX. "Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis". PLoS One 9(2014):e92267.
Ebbeson RL, Schreiber RA. "Diagnosing autoimmune hepatitis in children: is the International Autoimmune Hepatitis Group scoring system useful?". Clin Gastroenterol Hepatol 2(2004):935-940.
Rigopoulou EI, Mytilinaiou M, Romanidou O, Liaskos C, Dalekos GN. "Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis". J Autoimmune Dis 4(2007):2.
Choi G, Peters MG. "The challenge of diagnosing autoimmune hepatitis: less is more". Hepatology 48(2008):10-12.
Kirstein MM, Metzler F, Geiger E, Heinrich E, Hallensleben M, Manns MP, Vogel A. "Prediction of short- and long-term outcome in patients with autoimmune hepatitis". Hepatology 62(2015):1524-1535.
Zachou K, Gampeta S, Gatselis NK, Oikonomou K, Goulis J, Manoussakis MN, Dalekos GN. "Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis". Liver Int 35(2015):660-672.
Zachou K, Weiler-Normann C, Muratori L, Duarte-Rey C, Lohse AW, Dalekos GN. "Permanent immunosuppression in SLA/LP-positive autoimmune hepatitis is required although overall response and survival are similar". Liver Int 40(2020):368-376.
Czaja AJ. "Performance parameters of the diagnostic scoring systems for autoimmune hepatitis". Hepatology 48(2008):1540-1548.
Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, Heneghan MA. "Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease". Hepatology 50(2009):538-545.
Qiu D, Wang Q, Wang H, Xie Q, Zang G, Jiang H, et al. "Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients". J Hepatol 54(2011):340-347.
Czaja AJ, Carpenter HA. "Validation of a scoring system for the diagnosis of autoimmune hepatitis". Dig Dis Sci 41(1996):305-314.
Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. "Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis". Hepatology 23(1996):1369-1376.
Mileti E, Rosenthal P, Peters MG. "Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children". Clin Gastroenterol Hepatol 10(2012):417-421.
Arcos-Machancoses JV, Molera Busoms C, Julià Benazet A, Bovo MV, Quintero Bernabeu J, Juampere Rey A, et al. "Accuracy of the 2008 simplified criteria for the diagnosis of autoimmune hepatitis in children". Pediatr Gastroenterol Hepatol Nutr 21(2018):118-126.
Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D, et al. "Consensus recommendations for histological criteria of autoimmune hepatitis from the International AIH Pathology Group". Liver Int 42(2022):1058-1069.
Gatselis NK, Zachou K, Koukoulis GK, Dalekos GN. "Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics". World J Gastroenterol 21(2015):60-83.
Zachou K, Muratori P, Koukoulis GK, Granito A, Gatselis N, Fabbri A, Dalekos GN. "Review article: autoimmune hepatitis - current management and challenges". Aliment Pharmacol Ther 38(2013):887-913.
Muratori P, Lalanne C, Barbato E, Fabbri A, Cassani F, Lenzi M, Muratori L. "Features and progression of asymptomatic autoimmune hepatitis in Italy". Clin Gastroenterol Hepatol 14(2016):139-146.
Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. "Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases". Hepatology 72(2020):671-722.
Dalekos GN, Koskinas J, Papatheodoridis GV. "Hellenic Association for the Study of the Liver clinical practice guidelines: autoimmune hepatitis". Ann Gastroenterol 32(2019):1-23.
Beland K, Lapierre P, Marceau G, Alvarez F. "Anti-LC autoantibodies in patients with chronic hepatitis C virus infection". J Autoimmun 22(2004):159-166.
Rigopoulou EI, Zachou K, Gatselis N, Koukoulis GK, Dalekos GN. "Autoimmune hepatitis in patients with chronic HBV and HCV infections: patterns of clinical characteristics, disease progression and outcome". Ann Hepatol 13(2014):127-135.
Dalekos GN, Gatselis NK, Zachou K, Koukoulis GK. "NAFLD and autoimmune hepatitis: do not judge a book by its cover". Eur J Intern Med 75(2020):1-9.
Montano-Loza AJ, Vargas-Vorackova F, Ma M, Bain VG, Burak K, Kumar T, Mason AL. "Incidence and risk factors associated with de novo autoimmune hepatitis after liver transplantation". Liver Int 32(2012):1426-1433.
Dalekos GN, Zachou K, Liaskos C, Gatselis N. "Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview". Eur J Intern Med 13(2002):293-303.
Gatselis NK, Zachou K, Papamichalis P, Koukoulis GK, Gabeta S, Dalekos GN, Rigopoulou EI. "Comparison of simplified score with the revised original score for the diagnosis of autoimmune hepatitis: a new or a complementary diagnostic score?". Dig Liver Dis 42(2010):807-812.
Wong LL, Fisher HF, Stocken DD, Rice S, Khanna A, Heneghan MA, Oo YH, Mells G, Kendrick S, Dyson JK, Jones DEJ. "The impact of autoimmune hepatitis and its treatment on health utility". Hepatology 68(2018):1487-1497.
Pape S, Snijders RJALM, Gevers TJG, Chazouilleres O, Dalekos GN, Hirschfield GM, et al. "Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group". J Hepatol 76(2022):841-849.
